Home/Investors/Catalio Capital Management

Catalio Capital Management

Biotech Investor · 2 portfolio companies

Portfolio

2

Focus Areas

5

Top Stage

Phase 2

Investment Focus

Neuropsychiatric Disorders Cognitive Disorders Major Depressive Disorder Alzheimer's Disease Ophthalmology

Portfolio Companies

Company	Stage	Valuation	Focus
Syndeio Biosciences	Phase 2	—	Neuropsychiatric Disorders, Cognitive Disorders
Orasis Pharmaceuticals	commercial	—	Ophthalmology

Frequent Co-Investors

Johnson & Johnson Innovation – JJDC1 shared Arboretum Ventures1 shared Innoviva1 shared LifeSci Venture Partners1 shared Sequoia Capital1 shared Visionary Ventures1 shared Bluestem Capital1 shared SBI (Japan) Innovation Fund1 shared